Alkermes plc EPS Q/Q

Mi az Alkermes plc EPS Q/Q?

A EPS Q/Q az Alkermes plc - -85.71%

Mi a EPS Q/Q meghatározása?



A negyedévenkénti EPS negyedéves növekedési ráta az elmúlt 4 negyedévben a vállalat EPS-jének növekedése az előző 4 negyedév teljesítményéhez képest.

The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

EPS Q/Q a Health Care szektor a NASDAQ-on cégekben a Alkermes plc -hoz képest

Mit csinál Alkermes plc?

alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.

eps q/q -hoz hasonló cégek Alkermes plc